ACP3 and neoplasm: In these studies, we evaluated ACPP–drug conjugates in preclinical syngeneic cancer models grown in immune-competent mice, which are essential to interrogate how cancer therapies modulate tumor immune responses, which can then inform rational integration with cancer immunotherapies.